NCT07166666View on ClinicalTrials.gov

Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)

NANot yet recruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

October 1, 2026

Conditions
SedationAnalgesia Assessment
Interventions
DEVICE

atomizer

use atomizer to provide the medication in procedure sedation

DRUG

rescue medication

will be used as rescue if the atomizer medication not fully sedated

DRUG

Midazolam

Intranasal administration for procedural sedation.

DRUG

fentanyl

Intranasal administration for procedural sedation.

DRUG

Dexmedetomidine

Intranasal administration for procedural sedation.

DRUG

Placabo

use atomizer to provide the placebo in procedure sedation

Trial Locations (1)

Unknown

dr.Suad al baluish, Muscat

All Listed Sponsors
lead

Oman Medical Speciality Board

OTHER_GOV

NCT07166666 - Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old) | Biotech Hunter | Biotech Hunter